What Happens Afterward

Part of Consent and Vulnerable Populations: Emergency and Deferred Consent.

About 5 minutes. Free, in your language, no account needed.

Why this matters

Enrollment without prior consent is not consent waived. It is consent deferred, and the deferral creates an obligation that arrives days or weeks later, when the emergency is over and the people involved have moved on.

The obligation is routinely under-designed, because the difficult part of these trials feels like the enrollment and the design attention goes there.

What must happen

Consent must be sought as soon as practicable. From the participant if they recover capacity, and from their representative otherwise. "As soon as practicable" means as soon as the person is able to have the conversation, not at the next scheduled visit.

From the participant themselves where possible. A representative's consent obtained after the fact does not substitute for the participant's own once they can give it. The order is the participant first.

They must be told what was done. Fully. That they were enrolled while unable to agree, on what basis, what was administered, what has happened since, and what the trial involves from here.

They may decline to continue, and they may decline to have their data used, subject to what the framework provides about data already collected.

All of it is documented: when capacity returned or a representative became available, when consent was sought, by whom, and what was decided.

The conversation

Harder than any other consent conversation in research, and it is worth preparing for specifically.

The participant is being told that something was done to them without their agreement. Even where it was lawful, necessary and beneficial, that is a difficult thing to hear, and the manner of telling matters.

What helps: telling them early in the conversation rather than after a preamble; being plain that they were enrolled without consent and why; explaining that this is a defined lawful mechanism rather than an oversight; being clear that the decision from here is theirs; and giving them time.

What does not help: framing it as routine, minimizing it, or seeking a signature in the same conversation in which they learn of it. A participant who signs while still absorbing what they have been told has not consented in the sense that matters.

Anger is a legitimate response. Some participants will be upset, and being upset is not a complication to be managed. It is a reasonable reaction to what they are being told, and the conversation should be able to hold it.

When the participant dies

In emergency research a proportion of participants will not survive.

The obligations do not simply lapse. Depending on the framework, the representative may still need to be informed and asked about the use of data collected, and the family will in any case frequently learn that their relative was in a trial.

How that is handled is a matter of decency as much as of compliance. A family learning incidentally that their relative was enrolled in research during their final hours, from a document or an invoice, is a serious failure regardless of what the framework required.

Plan for it: who informs the family, when, how, and what is offered.

In practice

A cardiac arrest trial enrolls under the emergency exception. The team designs the deferred consent process with as much care as the enrollment process.

A defined owner checks daily whether each enrolled participant has regained capacity. An information sheet written specifically for this conversation explains what happened and why, in plain language, and is given to the participant to read before the conversation rather than during it.

The conversation happens at least a day after the participant is able, not at the first moment they are technically capable. Consent is sought in a second conversation.

For participants who die, a defined process: the family is informed by a named clinician, in person where possible, and told what the trial was, what was given, and who to contact.

Over the trial, three participants decline to continue and two families ask that data not be used. Both are accommodated.

The design of the afterward took as long as the design of the enrollment, which is the correct ratio and is unusual.

What this looks like when it goes wrong

A participant is enrolled in a trauma trial under the emergency exception. He recovers well and is discharged after nine days.

Deferred consent is sought at his first outpatient follow-up, five weeks later, because that is the first scheduled study contact.

He learns then, for the first time, that he received an investigational product during his admission.

He is not angry about the enrollment, which he accepts was necessary. He is angry that he was in the hospital for nine days, spoke to research staff, and was told nothing until five weeks after discharge.

He is right. He had capacity from about day four, and "as soon as practicable" was day four or five, not week five. The trial's process attached the deferred consent to a scheduled visit because that was administratively convenient, and convenience is not the standard.

Key takeaways